Scholars Central

Conference abstract

T-cellâ??based therapeutic modality in solid tumours

Authors: Weidong Han

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The clinical successes of CD19-targeted chimeric antigen receptor (CAR) T-cell treatment in B-cell lineage hematopoietic malignancies in recent years, especially in acute lymphocytic leukemia (ALL), have shown that tumour cells can be precisely and efficiently targeted and eliminated by tumour-associated antigen-redirected immune cells. However, consideration of the significant differences between liquid and solid tumours is needed to ascertain rational, feasible, and efficient CAR T-cellâ??based therapeutic modalities in solid tumours. How to precisely instruct transfused CAR T cells to attack tumour cells growing outside of normal circulation is still a great challenge. Herein, we would like to briefly introduce CD20-, CD30-directed CAR T trials in patients with refractory lymphomas, and will emphatically address the results from our clinical trial data in patients with relapsed/refractory solid tumours treated by autoglous EGFR-, HER2-, and CD133-directed CAR T-based therapeutic modality.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Weidong Han”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels